Episode 3: CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia
Medscape,
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple…
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple…
BALTIMORE – Having completed a strategic reorganization around its minimal residual disease testing and immune medicine…
BALTIMORE – Having completed a strategic reorganization around its minimal residual disease testing and immune medicine…
Researchers say they have identified a reliable predictor of relapse after chimeric antigen receptor (CAR) T-cell therapy in…
DNA sequencing to detect minimal residual disease and eventual relapse was more accurate than flow cytometry for adult and…
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA…
NEW YORK – Minimal residual disease (MRD) detection in bone marrow in the months after treatment appears to predict relapse in…
In paediatric and young adult patients withacute lymphoblastic leukaemia(ALL) treated with tisagenlecleucel, DNA sequencing-based…
Oncology/Hematology > Leukemia Nearly all patients with detectable disease relapsed or progressed to transplant, other…
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA…
Using next-generation DNA sequencing, researchers at Children’s Hospital of Philadelphia (CHOP) and others were able to analyze…
Credit: CC0 Public Domain In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with…
Bottom Line: In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah…
Bottom Line: In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah…
American Association for Cancer Research Bottom Line: In pediatric and young adult patients with acute lymphoblastic leukemia (AL…